A recent study in Colombia showed that no child was reactive to the rapid tests for hepatitis B, indicating that Colombia had probably achieved the goal of eliminating mother-to-child transmission of hepatitis B as a result of three decades of immunization programs and campaigns.
This study helps to estimate the prevalence of hepatitis B in children between 5 and 10 years of age, using an innovative two-stage methodology. It offers a moderately-priced option for monitoring progress toward the goal of eliminating hepatitis B in resource-limited countries that have good epidemiological data and disaggregated records that enable local-level analysis of hepatitis B in pregnant women, adults, and children, vaccination coverage against hepatitis B in newborns and coverage of the third dose of pentavalent vaccine, coverage of institutional childbirth, and, in particular, previous HBV prevalence studies
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.